To date, there are only two studies that report that the expression of CD151 mRNA and protein abundance are modulated by therapies – anti-epileptic drugs and anti-cancer drugs, respectively (Hua et al., 2001; Hwang et al., 2019). Here, CD151 is linked to cancer.